Advertisement

Oxidants and Antioxidants in Platelet Function

  • Jane E. Freedman
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 224)

Abstract

Epidemiological studies have shown that dietary antioxidant consumption is inversely associated with the development of coronary artery disease. The precise mechanisms that underlie these observations, however, are not clear. While the beneficial effects of antioxidants have been attributed to the prevention of oxidative modification of low-density lipoprotein (LDL) and the inhibition of atherogenesis, other factors may also be important. Platelet fonction is dependent upon the balance between oxidative stress and antioxidant protection and, importantly, platelets have been implicated in the development of atherosclerosis, as well as in the acute occlusion of coronary vessels (1,2).

Keywords

Nitric Oxide Platelet Aggregation Glutathione Peroxidase Platelet Function Human Platelet 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Davies MJ, Thomas AC: Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984; 310:1137.PubMedCrossRefGoogle Scholar
  2. 2.
    David M. A macro and micro view of coronary vascular insult with ischemic heart disease. Circulation. 1990;82:1–138.CrossRefGoogle Scholar
  3. 3.
    DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocrdial infarction. N Engl J Med. 1980;303:897.PubMedCrossRefGoogle Scholar
  4. 4.
    Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985;71:699.PubMedCrossRefGoogle Scholar
  5. 5.
    Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombis. Brit Heart J. 1983;1983:127.CrossRefGoogle Scholar
  6. 6.
    de Graff JC, Banga JD, Moncada S, Palmer RMJ, de Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation. 1992;85:2284.CrossRefGoogle Scholar
  7. 7.
    Radomski MW, Palmer MJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophysic Res Comm. 1987;148:1482.CrossRefGoogle Scholar
  8. 8.
    Santol MT, Valles J, Marcus AJ, Safier M, Brodkman J, Islan N, Ullman HL, Eirosa AM, Aznar J. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest. 1991;87:571.CrossRefGoogle Scholar
  9. 9.
    Fitzgerald DJ, Roy L, Catella F, FitzGerald GA: Platelet activation in unstable coronary disease. N Engl J Med. 1986;315:983.PubMedCrossRefGoogle Scholar
  10. 10.
    The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet. 1990;336:827.CrossRefGoogle Scholar
  11. 11.
    Antiplatelet Trialists Collaboration. Collaborative overview of randomized trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and sroke by prolonged antiplatelet therapy in various categories of patients. Brit Med J. 1994;308:81.CrossRefGoogle Scholar
  12. 12.
    Riemersma RA, Wood DA, Macintyre CCH, Elton RA, Gey KF, Oliver MF: Risk of angina pectoris and plasma concentrations of vitamins A, C, E, and carotene. Lancet. 1991;337:1.PubMedCrossRefGoogle Scholar
  13. 13.
    Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in men. N Eng J Med. 1993;328:1444.CrossRefGoogle Scholar
  14. 14.
    Buczynski AB, Wachowicz B, Dedziora-Kornatowska K, Tkaczewski W, Kedziora J. Changes in antioxidant enzyme activities, aggregability, and malonyldialdehyde concentrations in blood platelet from patients with coronary heart disease. Atherosclerosis. 1993;100:223.PubMedCrossRefGoogle Scholar
  15. 15.
    Bressler N, Broekman M, Marcus A. Concurrent studies of oxygen consumption and aggregation in stimulated human platelets. Blood. 1979;53:167.PubMedGoogle Scholar
  16. 16.
    Burch JW, Burch PT: Glutathione disulfide production during arachidonic acid oxygenation in human platelets. Prostaglandins. 1990;39:123.PubMedCrossRefGoogle Scholar
  17. 17.
    Marcus AJ, Silk ST, Safier LB, Ullman HL. Superoxide production and reducing activity in human platelets. J Clin Invest. 1977;59:149.PubMedCrossRefGoogle Scholar
  18. 18.
    Freedman JE, Keaney JF, Jr.: NO and Superoxide detection in human platelets. In: Packer L, ed. Nitric Oxide, Part C: Biological and Antioxidants Activities. Vol 301. San Diego, CA: Academic Press, 1998.Google Scholar
  19. 19.
    Handin RI, Karabin R, Boxer GJ: Enhancement of platelet function by Superoxide anion. J Clin Invest. 1987;59:149.Google Scholar
  20. 20.
    Stuart M, Holmsen H. Hydrogen peroxide, an inhibitor of platelet function: effect on adenine nucleotide metabolism, and the release reaction. Am J Hematol. 1977;2:53.PubMedCrossRefGoogle Scholar
  21. 21.
    Handin RI, Karabin R, Boxer GJ: Enhancement of platelet function by Superoxide anion. J Clin Invest. 1977;59:959.PubMedCrossRefGoogle Scholar
  22. 22.
    Rodvien R, Lindon J, Levine P. Physiology and ultrastructure of the blood platelet following exposure to hydrogen peroxide. Brit J Haematol. 1976;33:19.CrossRefGoogle Scholar
  23. 22a.
    Irani K, Pham Y, Coleman LD, Roos C, Cooke GE, Miodovnik A, Karim N, Wildhide CC, Goldscmidt-Clermont PJ. Priming of platelet α1β3 by oxidants is associated with tyrosine phosphorylation of β3. Arterioscler Thromb Vasc Biol 1998;18:1698.PubMedCrossRefGoogle Scholar
  24. 23.
    Marcus A. Pathways of oxygen utilization by stimulated platelets and leukocytes. Semin Hamatol. 1979;16:188.Google Scholar
  25. 24.
    Kooy M, Akkerman W, Van Asbeck S, Borghuis L, Van Prooijen H. UVB radiation exposed fibrinogen binding sites on platelets by activating protein kinase C via reactive oxygen speces. Brit J Haematol. 1992;83:253.CrossRefGoogle Scholar
  26. 25.
    Calzada C, Vericei E, Lagarde M. Decrease in platelet reduction glutathione increases lipoxygenase activity and decreasee vitamin E. Lipids. 1991;26:696.PubMedCrossRefGoogle Scholar
  27. 26.
    Vatassery G, Smith W, Quack H. Ascorbate acid, glutathione and synthetic antioxidants prevent the oxidation of vitamin E in platelets. Lipids. 1989;24:1043.PubMedCrossRefGoogle Scholar
  28. 27.
    Chan AC, Tran K, Raynor T, Ganz PR, Chow CK: Regeneration of vitamin E in human platelets. J Biol Chem. 1991;266:17290.PubMedGoogle Scholar
  29. 28.
    Schiavon R, Freeman G, Guidi G, Perona G, Zatti M, Kakkar V. Selenium enhances prostacyclin production by cultured endothelial cells: possible explanation for increased bleeding times in volunteers taking selenium as a dietary supplement. Thrombosis Res. 1984;34:389.CrossRefGoogle Scholar
  30. 29.
    Schoene N, Morris V, Levander O. Altered arachidonic acid metabolism in platelets and artas from selenium-deficient rats. Nutrtion Res. 1986;6:75.CrossRefGoogle Scholar
  31. 30.
    Johnson M, Ramey E, Ramwell P. Sex and age differences in human platelet aggregation. Nature. 1975;253:355.PubMedCrossRefGoogle Scholar
  32. 31.
    Vericel E, Rey C, Calzada C, Haond P, Capuy P, Lagarde M. Age-related changes in arachidonic acid peroxidation and glutathione-peroxidase activity in human platelets. Prostaglandins. 1992;43:75.PubMedCrossRefGoogle Scholar
  33. 32.
    Blache D. Involvement of hydrogen and lipid peroxidase in acute tobacco smoking-induced platelet hyperactivity. Am J Physiol. 1995;268:H679.PubMedGoogle Scholar
  34. 33.
    The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cander and other cancers in male smokers. N Engl J Med. 1994;330:1029.CrossRefGoogle Scholar
  35. 34.
    Higashi O, Kikuchi Y: Effects of vitamin E on the aggregation and the lipid peroxidation of platelets exposed to hydrogen peroxide. Tohoku J Exp Med. 1974;112:271.PubMedCrossRefGoogle Scholar
  36. 35.
    Steiner M, Anastasi J: Vitamin E: an inhibitor of the platelet release reaction. J Clin Invest. 1976;57:732.PubMedCrossRefGoogle Scholar
  37. 36.
    Jandak J, Steiner M, Richardson P. Alpha-tocopherol, an effective inhibitor of platelet adhesion. Blood. 1982;73:141.Google Scholar
  38. 37.
    Steiner M: Effect of α-tocopherol administration on platelet function in man. Thromb Haemost. 1983;49:73.PubMedGoogle Scholar
  39. 38.
    Baldassare JJ, Henderson P, Burns D, Loomis C, Fischer GJ: Translocation of protein kinase C isoenzymes thrombin-stimulated human platelets — correlation with 1,2 diacylglycerol levels. J Biol Chem. 1992;267:15585.PubMedGoogle Scholar
  40. 39.
    Kroll MH, Heliums JD, Guo Z, Durante W, Razdan D, Hrbolich JK, Schafer AI: Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem. 1993;268:3520.PubMedGoogle Scholar
  41. 40.
    Mahoney CW, Azzi A: Vitamin E inhibits protein kinase C activity. Biochem Biophys Res Commun. 1988;154:694.PubMedCrossRefGoogle Scholar
  42. 41.
    Freedman JE, Farhat JH, Loscalzo J, Keaney JF, Jr.: α-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation. 1996;94:2434.PubMedCrossRefGoogle Scholar
  43. 42.
    Stamler J, Mendelsohn ME, Amarante P, Smick D, Andon N, Davies PF, Cooke JP, Loscalzo J. N-Acetylcysteine potentiates platelet inhibition by enodhtleium-derived relaxing factor. Circ Res. 1989;65:789.PubMedCrossRefGoogle Scholar
  44. 43.
    Cooke JP, Stamler J, Andon N, Davies PF, McKinley G, Loscalzo J: Flow stimulates endothelial cells to release nitrovasodilator that is potentiated by reduced thiol. Am J Physiol. 1990;259:H804.PubMedGoogle Scholar
  45. 44.
    Shultz PJ, Raij L: Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest. 1992;90:1718.PubMedCrossRefGoogle Scholar
  46. 45.
    Michelson AD, Benoit SE, Furman MI, Breckwoldt WL, Rohter MJ, Barnard MR, Loscalzo J: Effects of endotheium-derived relaxing factor/nitric oxide on platelet surface glycoproteins. Am J Physiol. 1996;39:H1640.Google Scholar
  47. 46.
    Mehta JL, Chen LY, Kone BC, Mehta P, Turner P: Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med. 1995; 125:370.PubMedGoogle Scholar
  48. 47.
    Sase K, Michel T: Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci. 1995;57:2049.PubMedCrossRefGoogle Scholar
  49. 48.
    Chen LY, Mehta JL: Variable effects of L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms. J Pharmacol Exp Ther. 1996;267:253.Google Scholar
  50. 49.
    Simon DI, Stamler JS, Loh E, Loscalzo J, Francis SA, Creager MA: Effect of nitric oxide synthase inhibition on bleeding time in humans. J Cardiovasc Pharmacol. 1995;26:339.PubMedCrossRefGoogle Scholar
  51. 50.
    Bodzenta-Lukaszyke A, Gabryelewicz A, Lukaszyke A, Bielawiec M, Konturek JW, Domschke W. Nitric oxide synthase inhibition and platelet function. Thromb Res. 1994;75:667.CrossRefGoogle Scholar
  52. 51.
    Zhou Q, Hellermann GR, Solomonson LP: nitric oxide release from resting human platelets. Thromb Res. 1995;77:87.PubMedCrossRefGoogle Scholar
  53. 52.
    Malinski T, Radomski MW, Taha Z, Moncada S: Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Comm. 1993;194:960.PubMedCrossRefGoogle Scholar
  54. 53.
    Radomski MW, Palmer RMJ, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 1990;87:5193.PubMedCrossRefGoogle Scholar
  55. 54.
    Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Jr., Michelson AD: Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest. 1997; 100:350.PubMedCrossRefGoogle Scholar
  56. 55.
    Freedman JE, Ting B, Hankin B, Loscalzo J, Keaney JF, Jr., Vita JA: Impaired platelet production of nitric oxide predicts the presence of acute coronary syndromes. Circulation. 1998;In press.Google Scholar
  57. 56.
    Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest. 1986; 170.Google Scholar
  58. 57.
    Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P: Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491.PubMedCrossRefGoogle Scholar
  59. 58.
    Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial Superoxide anion production. J Clin Invest. 1993;91:2546.PubMedCrossRefGoogle Scholar
  60. 59.
    Lynch SM, Frei B: Mechanisms of copper-and iron-dependent oxidative modification of human low-density lipoprotein. J Lipid Res. 1993;34:1745.PubMedGoogle Scholar
  61. 60.
    Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA: Nitric oxide regulation of Superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem. 1994;269:26066.PubMedGoogle Scholar
  62. 61.
    Gryglewski RJ, Palmer RM, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454.PubMedCrossRefGoogle Scholar
  63. 62.
    Kissner R, Nauser T, Bugnon P, Lye PG, Koppenol WH: Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. Chemical Res Toxicol. 1997;10:1285.CrossRefGoogle Scholar
  64. 63.
    Meng YY, Trachtenburg J, Ryan US, Abendschein DR: Potentiation of endogenous nitric oxide with Superoxide dismutase inhibits platelet-mediated thrombosis in injured and stenotic arteries. J Am Coll Cardiol. 1995;25:269.PubMedCrossRefGoogle Scholar
  65. 64.
    Ikeda H, Koga Y, Od T, Kuwano K, Nakayama H, Ueno T, Toshima H, Michael L, Entman M. Free oxygen radicals contribute to plattet aggregation and cyclic flow variations in stenosed and endothelium-injred canine coronary arteries. J Am Coll Cardiol. 1994;24:1749.PubMedCrossRefGoogle Scholar
  66. 65.
    Freedman JE, Frei B, Welch GN, Loscalzo J: Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest. 1995;96:394.PubMedCrossRefGoogle Scholar
  67. 66.
    Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barnard MR, Michelson AD: Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest. 1996;97:979.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Jane E. Freedman

There are no affiliations available

Personalised recommendations